Literature DB >> 7128674

Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.

M J Herfst, F A De Wolff.   

Abstract

The influence of food on the kinetics of 8-methoxypsoralen (8-MOP) in serum and suction blister fluid was evaluated in a cross-over study in 19 psoriatic patients under PUVA treatment. The peak serum concentration of 8-MOP was reached 1.5 h after ingestion on an empty stomach, and in suction blister fluid the maximum concentration was already present in the first sample taken after 2 h, the time when UVA radiation was given. The postprandial kinetics of 8-MOP in serum and suction blister fluid differed, the highest levels being reached, respectively, at 2.4 and 3 h after intake, i.e. in both body fluids after irradiation had started. The side effects of 8-MOP, such as nausea and dizziness, in the two groups were similar. The present results indicate that to optimize the therapeutic effect of PUVA in individual patients, 8-MOP should be given on an empty stomach.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128674     DOI: 10.1007/bf01061380

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.

Authors:  J A Parrish; T B Fitzpatrick; L Tanenbaum; M A Pathak
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

2.  Current status of oral PUVA therapy for psoriasis.

Authors: 
Journal:  J Am Acad Dermatol       Date:  1979-08       Impact factor: 11.527

3.  Determination of 8-methoxypsoralen in suction-blister fluid and serum by liquid chromatography.

Authors:  M J Herfst; P M Edelbroek; F A de Wolff
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

4.  Suction blister fluid as a model for interstitial fluid in rats.

Authors:  M J Herfst; H van Rees
Journal:  Arch Dermatol Res       Date:  1978-12-01       Impact factor: 3.017

5.  Photochemotherapy for psoriasis.

Authors:  H H Roenigk; J S Martin
Journal:  Arch Dermatol       Date:  1977-12

6.  Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin.

Authors:  U Kiistala; K K Mustakallio
Journal:  J Invest Dermatol       Date:  1967-05       Impact factor: 8.551

7.  Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.

Authors:  J W Melski; L Tanenbaum; J A Parrish; T B Fitzpatrick; H L Bleich
Journal:  J Invest Dermatol       Date:  1977-06       Impact factor: 8.551

8.  Difference in bioavailability between two brands of 8-methoxypsoralen and its impact on the clinical response in psoriatic patients.

Authors:  M J Herfst; F A De Wolff
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

9.  May mothers taking acenocoumarol breast feed their infants?

Authors:  M Houwert-de Jong; L J Gerards; C A Tetteroo-Tempelman; F A de Wolff
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Pharmacokinetics and metabolite-pattern of 8-methoxypsoralen in man following oral administration as compared to the pharmacokinetics in rat and dog.

Authors:  U Busch; J Schmid; F W Koss; H Zipp; A Zimmer
Journal:  Arch Dermatol Res       Date:  1978-08-28       Impact factor: 3.017

View more
  3 in total

Review 1.  Photochemotherapy. A reappraisal of its use in dermatology.

Authors:  H Moseley; J Ferguson
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of methoxsalen and other psoralens.

Authors:  F A de Wolff; T V Thomas
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

3.  Food-induced increase in bioavailability of 5-methoxypsoralen.

Authors:  H Ehrsson; I Wallin; A M Ros; S Eksborg; M Berg
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.